Global Gastroesophageal Reflux Disease (GERD) Devices Market Size By Type (Diagnostic Devices, Treatment Devices), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Gastroesophageal Reflux Disease (GERD) Devices Market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.3 billion by 2031, growing at a CAGR of 8.5% during the forecast period of 2023–2031. GERD devices are used to manage the symptoms and complications associated with chronic acid reflux conditions. The increasing global prevalence of GERD, advancements in minimally invasive surgical techniques, and the growing preference for non-pharmacological interventions are key contributors to market growth. As healthcare systems focus on improving patient outcomes and reducing long-term pharmaceutical dependency, the adoption of GERD devices is expanding across hospitals, clinics, and ambulatory surgical centers.

Drivers

1. Rising Prevalence of GERD:

The global incidence of GERD is rising due to sedentary lifestyles, obesity, poor dietary habits, and aging populations. This growing patient pool is fueling the demand for effective treatment options, including GERD devices.

2. Technological Advancements in GERD Treatment:

Innovations such as magnetic sphincter augmentation devices and implantable reflux management systems are enhancing the efficacy and safety of GERD treatments. These advancements are improving patient compliance and reducing complications compared to traditional drug therapies.

3. Preference for Minimally Invasive Procedures:

Patients and healthcare providers are increasingly opting for minimally invasive GERD treatments, which offer faster recovery times, fewer complications, and shorter hospital stays. This trend is propelling the demand for advanced GERD devices.

Restraints

1. High Cost of GERD Devices and Procedures:

Despite clinical efficacy, GERD devices and the associated surgical procedures are often expensive and may not be fully covered by insurance, particularly in developing regions. This financial barrier limits market penetration.

2. Limited Awareness Among Patients:

In many parts of the world, there is limited awareness about GERD device-based interventions. Patients often rely on over-the-counter medications, delaying effective treatment and impacting the growth of device adoption.

Opportunity

1. Expansion into Emerging Markets:

Emerging economies are witnessing improvements in healthcare infrastructure and increased healthcare spending. These developments present lucrative opportunities for GERD device manufacturers to expand their presence in countries like India, Brazil, and Southeast Asia.

2. Integration with Telemedicine Platforms:

The integration of GERD management devices with remote monitoring tools and telehealth platforms offers enhanced patient follow-up and treatment optimization, paving the way for broader device adoption and improved healthcare access.

Market by System Type Insights

The Magnetic Sphincter Augmentation segment dominated the GERD devices market in 2023, owing to its superior effectiveness in managing GERD symptoms and its minimally invasive nature. This segment is expected to retain its lead throughout the forecast period. Meanwhile, the Endoscopic Therapy Devices segment is anticipated to exhibit the fastest growth, driven by increasing demand for outpatient procedures and technological innovations that make endoscopic options more accessible and cost-effective.

Market by End-use Insights

Hospitals emerged as the largest end-use segment in 2023, accounting for the majority of the market share due to the availability of specialized surgical expertise and infrastructure. However, Ambulatory Surgical Centers are expected to grow at the highest rate, attributed to lower procedural costs, shorter patient stay, and increasing preference for outpatient care among patients.

Market by Regional Insights

North America led the global GERD devices market in 2023, driven by high disease prevalence, favorable reimbursement policies, and strong healthcare infrastructure. Europe followed, supported by increased adoption of advanced surgical procedures. The Asia-Pacific region is projected to witness the highest CAGR during the forecast period, fueled by a growing patient population, rising awareness, and healthcare advancements in countries such as China and India.

Competitive Scenario

Key players operating in the Global GERD Devices Market include Medtronic plc, Johnson & Johnson (Ethicon), EndoGastric Solutions, Torax Medical (acquired by Johnson & Johnson), Medigus Ltd., Mederi Therapeutics Inc., and Crospon (Medtronic). These companies are focused on product innovation, regulatory approvals, and strategic partnerships to strengthen their market positions. Notable developments include:

In 2023, EndoGastric Solutions received FDA clearance for its next-gen EsophyX Z device, enhancing transoral incisionless fundoplication capabilities.

In 2024, Medtronic launched a connected GERD monitoring system compatible with telehealth platforms for remote patient management.

Scope of Work – Global Gastroesophageal Reflux Disease (GERD) Devices Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.3 billion

CAGR (2023–2031) 8.5%

Market Segments System Type (Magnetic Sphincter, Endoscopic, Radiofrequency), End-use (Hospitals, ASCs, Clinics)

Growth Drivers Rising GERD prevalence, Minimally invasive techniques, Technology innovations

Opportunities Emerging market penetration, Telemedicine integration

Key Market Developments

April 2023: EndoGastric Solutions introduced the EsophyX Z system for improved minimally invasive GERD treatment.

January 2024: Medtronic launched a smart reflux monitoring wearable integrated with digital health platforms for real-time tracking.

FAQs

1) What is the current market size of the Global Gastroesophageal Reflux Disease (GERD) Devices Market?

The market was valued at USD 1.2 billion in 2023.

2) What is the major growth driver of the Global GERD Devices Market?

The major driver is the rising prevalence of GERD and growing preference for minimally invasive treatments.

3) Which is the largest region during the forecast period in the Global GERD Devices Market?

North America holds the largest market share due to advanced healthcare systems and high disease incidence.

4) Which segment accounted for the largest market share in the Global GERD Devices Market?

The Magnetic Sphincter Augmentation segment accounted for the largest share in 2023.

5) Who are the key market players in the Global GERD Devices Market?

Key players include Medtronic plc, Johnson & Johnson, EndoGastric Solutions, Torax Medical, Medigus Ltd., and Mederi Therapeutics.